Skip to content

Frontal Bone Window in ICUF (FBW-ICU)

Assessment of Frontal Bone Window for Transcranial Doppler Among Acute Brain Injured Patients in Intensive Care Units: a Prospective Study.

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02832895
Acronym
FBW-ICU
Enrollment
150
Registered
2016-07-14
Start date
2015-07-31
Completion date
2016-12-30
Last updated
2018-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Brain Injury

Keywords

Adults, Frontal bone window, Transcranial doppler

Brief summary

Transcranial doppler (TCD) is an established tool for monitoring flows in intracranial cerebral arteries. Its use is recommanded in the last guidelines on traumatic brain injury. The temporal bone window (TBW) is limited in evaluating flow in the anterior cerebral arteries (ACA) because of an unfavorable insonation angle. Thereby TCD could be unfit to detect a segmental lesion on the anterior cerebral arteries (ACA). The frontal bone window (FBW) is a promising approach in evaluating flows in the ACA. However, the utility of the FBW for patients with acute brain injury (ABI) in ICU has not been yet determined. The goal of the present study is to determine the rate of detection of the ACA by using the FBW in patients with ABI in ICU.

Interventions

OTHERTranscranial doppler examination

Assessment of frontal bone window for transcranial doppler

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Membership in a health insurance scheme * Patients with an acute cerebral pathology * Hospitalized patients in a supportive care unit of Montpellier University Hospital * Be able to benefit from transcranial doppler within 3 days of admission

Exclusion criteria

* Clinical suspicion of encephalic death * Known allergy to ultrasound gel

Design outcomes

Primary

MeasureTime frame
measures of ACA flow velocities threw the frontal bone windowup to 72 hours

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026